The oneAPI Construction Kit of Codeplay Software is utilized for #hardware #acceleration in our Horizon Europe🇪🇺 project! We have also achieved to combine it with TornadoVM to unlock the execution of not only #C ++, but also #Java on #RISCV vector processors!
zenodo.org/record/7941059
J Curley @[email protected] TornadoVM Codeplay Software Thanks Joe! That is indeed a great project! We look forward advancing open software for hardware acceleration with Codeplay, oneAPI toolkits and TornadoVM!
Fun seeing progress in the ecosystem to broaden #AI through #JAX and #open accelerated computing on top of the #oneAPI stack and Intel #tensorflow extensions for new Intel Graphics ARC GPUs
cyberpogo.com/2023/06/09/acc…
mikiobraun 🪼 Erik Bernhardsson Lookup HIP from AMD. As for Intel GPUs you can get the recent discrete gaming ones for a decent price and hopefully use sycl/dpc++/oneAPI to program it. Good luck there.
Felix CLC (is considering offers) The good Hunter 🐀 AC_666__ Gaudi is probably never getting oneAPI support and since the Gaudi lineup is dead after Gaudi-3, it makes even less sense to allocate resources to add Gaudi support
Aksel Alpay It is quite unfortunate. I usually call the Intel compiler 'intel/llvm' to try to avoid confusion.
There's also the issue that some oneAPI libraries like oneDPL depend on a lot of intel/llvm extensions and don't work with other SYCL compilers (last time I checked).
Well deserved for Christos Kotselidis, Juan Fumero, Thanos Stratikopoulos and the whole TornadoVM team for the Intel research award! 👏
Recognition from Intel for the work implemented The University of Manchester for the ongoing efforts of supporting oneAPI to improve the #TornadoVM software platform.
Well done Christos Kotselidis and team!
Wanted to give a quick thanks to Intel Software, James Reinders and absurdum expectum @[email protected] for having me on as part of the OneAPI Accelerated compute panel yesterday.
Had a good time discussing what does and doesn't work across oneAPI, SYCL and how to deal with SYCL as a standard.
Our CEO, John Climaco, speaks to the Company’s dedicated mission of not only providing hope for #Glioblastoma patients but also a safe and effective treatment option. #RareDiseaseDay #ShowYourStripes #CareAboutRare